Townsend Adam J. 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Townsend Adam J.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-01-17$29.96/sh−2,201$65,938→ 88,068 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.